Global Pet Tumor Screening Services Supply, Demand and Key Producers, 2026-2032
The global Pet Tumor Screening Services market size is expected to reach $ 1056 million by 2032, rising at a market growth of 7.1% CAGR during the forecast period (2026-2032).
Pet Tumor Screening Service refers to a cancer risk assessment and early screening service for companion animals such as dogs and cats. It typically uses blood, urine, cytology samples, or other biological specimens to detect tumor-related biomarkers, nucleosome signals, circulating cell-free DNA, genetic mutations, epigenetic features, or abnormal cellular morphology, thereby helping assess potential cancer risk in pets. The service is commonly used in annual wellness checkups for senior pets, screening of high-risk breeds, adjunctive diagnosis for suspicious clinical signs, and post-treatment recurrence monitoring. It does not fully replace imaging, histopathology, or clinical diagnosis, but serves as an important front-end tool for early cancer detection and pet health management. The price of Pet Tumor Screening Services varies significantly, with basic blood- or urine-based screening typically priced at around USD 100?300 per test, while higher-end liquid biopsy, genomic, or epigenomic testing usually costs around USD 500?1,000 per test.
The upstream supply chain of Pet Tumor Screening Service includes antibodies, enzymes, primers and probes, sequencing reagents, sample collection tubes, preservation solutions, diagnostic kits, testing instruments, automated analysis platforms, AI pathology algorithms, and bioinformatics systems. Core reagents and analytical models directly influence test sensitivity, specificity, and result interpretation. Midstream participants mainly include veterinary diagnostic laboratories, pet molecular diagnostics companies, liquid biopsy developers, digital pathology platforms, and large pet healthcare groups, which are responsible for assay development, sample processing, laboratory testing, report generation, and clinical interpretation. Downstream users include veterinary hospitals, clinics, veterinary oncology centers, pet wellness providers, breeding institutions, and premium pet health management customers, with services delivered through clinic-based sample submission, in-clinic testing, at-home sample collection, or pet wellness packages.
The Pet Tumor Screening Service market is at an early growth stage, driven by the increasing sophistication and preventive orientation of pet healthcare. Demand is mainly supported by pet aging, rising owner awareness of health management, the growing burden of cancer in companion animals, and the upgrading of premium veterinary wellness packages. Compared with traditional pathology and imaging diagnostics, these services emphasize early screening, non-invasive or minimally invasive sampling, repeatable monitoring, and convenient delivery, giving them strong commercialization potential in senior pets, high-risk breeds, and post-treatment follow-up scenarios. Future competition will focus on test accuracy, clinical validation, veterinary channel coverage, report interpretability, price acceptance, and integration with imaging, pathology, and treatment services. Companies with strong brand trust and laboratory network advantages are more likely to achieve scalable growth.
This report studies the global Pet Tumor Screening Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pet Tumor Screening Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pet Tumor Screening Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pet Tumor Screening Services total market, 2021-2032, (USD Million)
Global Pet Tumor Screening Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Pet Tumor Screening Services total market, key domestic companies, and share, (USD Million)
Global Pet Tumor Screening Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Pet Tumor Screening Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Pet Tumor Screening Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Pet Tumor Screening Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IDEXX Laboratories, Zoetis Diagnostics, Antech Diagnostics, VolitionRx, VDI Laboratory, Oncotect, CanCan Diagnostics, Oxford BioDynamics, FUJIFILM VET Systems, Veterinary Pathology Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pet Tumor Screening Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pet Tumor Screening Services Market, By Region:
1. How big is the global Pet Tumor Screening Services market?
2. What is the demand of the global Pet Tumor Screening Services market?
3. What is the year over year growth of the global Pet Tumor Screening Services market?
4. What is the total value of the global Pet Tumor Screening Services market?
5. Who are the Major Players in the global Pet Tumor Screening Services market?
6. What are the growth factors driving the market demand?
Pet Tumor Screening Service refers to a cancer risk assessment and early screening service for companion animals such as dogs and cats. It typically uses blood, urine, cytology samples, or other biological specimens to detect tumor-related biomarkers, nucleosome signals, circulating cell-free DNA, genetic mutations, epigenetic features, or abnormal cellular morphology, thereby helping assess potential cancer risk in pets. The service is commonly used in annual wellness checkups for senior pets, screening of high-risk breeds, adjunctive diagnosis for suspicious clinical signs, and post-treatment recurrence monitoring. It does not fully replace imaging, histopathology, or clinical diagnosis, but serves as an important front-end tool for early cancer detection and pet health management. The price of Pet Tumor Screening Services varies significantly, with basic blood- or urine-based screening typically priced at around USD 100?300 per test, while higher-end liquid biopsy, genomic, or epigenomic testing usually costs around USD 500?1,000 per test.
The upstream supply chain of Pet Tumor Screening Service includes antibodies, enzymes, primers and probes, sequencing reagents, sample collection tubes, preservation solutions, diagnostic kits, testing instruments, automated analysis platforms, AI pathology algorithms, and bioinformatics systems. Core reagents and analytical models directly influence test sensitivity, specificity, and result interpretation. Midstream participants mainly include veterinary diagnostic laboratories, pet molecular diagnostics companies, liquid biopsy developers, digital pathology platforms, and large pet healthcare groups, which are responsible for assay development, sample processing, laboratory testing, report generation, and clinical interpretation. Downstream users include veterinary hospitals, clinics, veterinary oncology centers, pet wellness providers, breeding institutions, and premium pet health management customers, with services delivered through clinic-based sample submission, in-clinic testing, at-home sample collection, or pet wellness packages.
The Pet Tumor Screening Service market is at an early growth stage, driven by the increasing sophistication and preventive orientation of pet healthcare. Demand is mainly supported by pet aging, rising owner awareness of health management, the growing burden of cancer in companion animals, and the upgrading of premium veterinary wellness packages. Compared with traditional pathology and imaging diagnostics, these services emphasize early screening, non-invasive or minimally invasive sampling, repeatable monitoring, and convenient delivery, giving them strong commercialization potential in senior pets, high-risk breeds, and post-treatment follow-up scenarios. Future competition will focus on test accuracy, clinical validation, veterinary channel coverage, report interpretability, price acceptance, and integration with imaging, pathology, and treatment services. Companies with strong brand trust and laboratory network advantages are more likely to achieve scalable growth.
This report studies the global Pet Tumor Screening Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pet Tumor Screening Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pet Tumor Screening Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pet Tumor Screening Services total market, 2021-2032, (USD Million)
Global Pet Tumor Screening Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Pet Tumor Screening Services total market, key domestic companies, and share, (USD Million)
Global Pet Tumor Screening Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Pet Tumor Screening Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Pet Tumor Screening Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Pet Tumor Screening Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IDEXX Laboratories, Zoetis Diagnostics, Antech Diagnostics, VolitionRx, VDI Laboratory, Oncotect, CanCan Diagnostics, Oxford BioDynamics, FUJIFILM VET Systems, Veterinary Pathology Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pet Tumor Screening Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pet Tumor Screening Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Blood Biomarker-Based Tumor Screening Services
- Liquid Biopsy and Genomic Testing Services
- Urine-Based or Volatile Metabolite Screening Services
- AI Cytology and Digital Pathology Screening Services
- In-Clinic Point-of-Care Testing
- Central Reference Laboratory Testing
- At-Home Sample Collection and Mail-In Testing
- Integrated Veterinary Oncology Screening Services
- Annual Wellness Cancer Screening
- Adjunctive Diagnosis for Suspected Cancer
- Recurrence and Disease Monitoring
- High-Risk Breed Screening
- Pet Annual Wellness Checkups
- Initial Tumor Screening in Veterinary Clinics
- Post-Surgery and Post-Treatment Monitoring
- Premium Pet Healthcare and Insurance-Linked Screening
- IDEXX Laboratories
- Zoetis Diagnostics
- Antech Diagnostics
- VolitionRx
- VDI Laboratory
- Oncotect
- CanCan Diagnostics
- Oxford BioDynamics
- FUJIFILM VET Systems
- Veterinary Pathology Group
- NationWide Laboratories
- BioGuard Corporation
- PETcision Biotech
- Uni-Pharma
1. How big is the global Pet Tumor Screening Services market?
2. What is the demand of the global Pet Tumor Screening Services market?
3. What is the year over year growth of the global Pet Tumor Screening Services market?
4. What is the total value of the global Pet Tumor Screening Services market?
5. Who are the Major Players in the global Pet Tumor Screening Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pet Tumor Screening Services Introduction
1.2 World Pet Tumor Screening Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Pet Tumor Screening Services Total Market by Region (by Headquarter Location)
1.3.1 World Pet Tumor Screening Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.3 China Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.4 Europe Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.5 Japan Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.6 South Korea Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.8 India Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pet Tumor Screening Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Pet Tumor Screening Services Consumption Value (2021-2032)
2.2 World Pet Tumor Screening Services Consumption Value by Region
2.2.1 World Pet Tumor Screening Services Consumption Value by Region (2021-2026)
2.2.2 World Pet Tumor Screening Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Pet Tumor Screening Services Consumption Value (2021-2032)
2.4 China Pet Tumor Screening Services Consumption Value (2021-2032)
2.5 Europe Pet Tumor Screening Services Consumption Value (2021-2032)
2.6 Japan Pet Tumor Screening Services Consumption Value (2021-2032)
2.7 South Korea Pet Tumor Screening Services Consumption Value (2021-2032)
2.8 ASEAN Pet Tumor Screening Services Consumption Value (2021-2032)
2.9 India Pet Tumor Screening Services Consumption Value (2021-2032)
3 WORLD PET TUMOR SCREENING SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Pet Tumor Screening Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pet Tumor Screening Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pet Tumor Screening Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Pet Tumor Screening Services in 2025
3.3 Pet Tumor Screening Services Company Evaluation Quadrant
3.4 Pet Tumor Screening Services Market: Overall Company Footprint Analysis
3.4.1 Pet Tumor Screening Services Market: Region Footprint
3.4.2 Pet Tumor Screening Services Market: Company Product Type Footprint
3.4.3 Pet Tumor Screening Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pet Tumor Screening Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pet Tumor Screening Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Pet Tumor Screening Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Pet Tumor Screening Services Consumption Value Comparison
4.2.1 United States VS China: Pet Tumor Screening Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pet Tumor Screening Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Pet Tumor Screening Services Companies and Market Share, 2021-2026
4.3.1 United States Based Pet Tumor Screening Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pet Tumor Screening Services Revenue, (2021-2026)
4.4 China Based Companies Pet Tumor Screening Services Revenue and Market Share, 2021-2026
4.4.1 China Based Pet Tumor Screening Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pet Tumor Screening Services Revenue, (2021-2026)
4.5 Rest of World Based Pet Tumor Screening Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Pet Tumor Screening Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Pet Tumor Screening Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pet Tumor Screening Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood Biomarker-Based Tumor Screening Services
5.2.2 Liquid Biopsy and Genomic Testing Services
5.2.3 Urine-Based or Volatile Metabolite Screening Services
5.2.4 AI Cytology and Digital Pathology Screening Services
5.3 Market Segment by Type
5.3.1 World Pet Tumor Screening Services Market Size by Type (2021-2026)
5.3.2 World Pet Tumor Screening Services Market Size by Type (2027-2032)
5.3.3 World Pet Tumor Screening Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SERVICE DELIVERY MODEL
6.1 World Pet Tumor Screening Services Market Size Overview by Service Delivery Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Service Delivery Model
6.2.1 In-Clinic Point-of-Care Testing
6.2.2 Central Reference Laboratory Testing
6.2.3 At-Home Sample Collection and Mail-In Testing
6.2.4 Integrated Veterinary Oncology Screening Services
6.3 Market Segment by Service Delivery Model
6.3.1 World Pet Tumor Screening Services Market Size by Service Delivery Model (2021-2026)
6.3.2 World Pet Tumor Screening Services Market Size by Service Delivery Model (2027-2032)
6.3.3 World Pet Tumor Screening Services Market Size Market Share by Service Delivery Model (2027-2032)
7 MARKET ANALYSIS BY SCREENING PURPOSE
7.1 World Pet Tumor Screening Services Market Size Overview by Screening Purpose: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Screening Purpose
7.2.1 Annual Wellness Cancer Screening
7.2.2 Adjunctive Diagnosis for Suspected Cancer
7.2.3 Recurrence and Disease Monitoring
7.2.4 High-Risk Breed Screening
7.3 Market Segment by Screening Purpose
7.3.1 World Pet Tumor Screening Services Market Size by Screening Purpose (2021-2026)
7.3.2 World Pet Tumor Screening Services Market Size by Screening Purpose (2027-2032)
7.3.3 World Pet Tumor Screening Services Market Size Market Share by Screening Purpose (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pet Tumor Screening Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pet Annual Wellness Checkups
8.2.2 Initial Tumor Screening in Veterinary Clinics
8.2.3 Post-Surgery and Post-Treatment Monitoring
8.2.4 Premium Pet Healthcare and Insurance-Linked Screening
8.3 Market Segment by Application
8.3.1 World Pet Tumor Screening Services Market Size by Application (2021-2026)
8.3.2 World Pet Tumor Screening Services Market Size by Application (2027-2032)
8.3.3 World Pet Tumor Screening Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 IDEXX Laboratories
9.1.1 IDEXX Laboratories Details
9.1.2 IDEXX Laboratories Major Business
9.1.3 IDEXX Laboratories Pet Tumor Screening Services Product and Services
9.1.4 IDEXX Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 IDEXX Laboratories Recent Developments/Updates
9.1.6 IDEXX Laboratories Competitive Strengths & Weaknesses
9.2 Zoetis Diagnostics
9.2.1 Zoetis Diagnostics Details
9.2.2 Zoetis Diagnostics Major Business
9.2.3 Zoetis Diagnostics Pet Tumor Screening Services Product and Services
9.2.4 Zoetis Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Zoetis Diagnostics Recent Developments/Updates
9.2.6 Zoetis Diagnostics Competitive Strengths & Weaknesses
9.3 Antech Diagnostics
9.3.1 Antech Diagnostics Details
9.3.2 Antech Diagnostics Major Business
9.3.3 Antech Diagnostics Pet Tumor Screening Services Product and Services
9.3.4 Antech Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Antech Diagnostics Recent Developments/Updates
9.3.6 Antech Diagnostics Competitive Strengths & Weaknesses
9.4 VolitionRx
9.4.1 VolitionRx Details
9.4.2 VolitionRx Major Business
9.4.3 VolitionRx Pet Tumor Screening Services Product and Services
9.4.4 VolitionRx Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 VolitionRx Recent Developments/Updates
9.4.6 VolitionRx Competitive Strengths & Weaknesses
9.5 VDI Laboratory
9.5.1 VDI Laboratory Details
9.5.2 VDI Laboratory Major Business
9.5.3 VDI Laboratory Pet Tumor Screening Services Product and Services
9.5.4 VDI Laboratory Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 VDI Laboratory Recent Developments/Updates
9.5.6 VDI Laboratory Competitive Strengths & Weaknesses
9.6 Oncotect
9.6.1 Oncotect Details
9.6.2 Oncotect Major Business
9.6.3 Oncotect Pet Tumor Screening Services Product and Services
9.6.4 Oncotect Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Oncotect Recent Developments/Updates
9.6.6 Oncotect Competitive Strengths & Weaknesses
9.7 CanCan Diagnostics
9.7.1 CanCan Diagnostics Details
9.7.2 CanCan Diagnostics Major Business
9.7.3 CanCan Diagnostics Pet Tumor Screening Services Product and Services
9.7.4 CanCan Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CanCan Diagnostics Recent Developments/Updates
9.7.6 CanCan Diagnostics Competitive Strengths & Weaknesses
9.8 Oxford BioDynamics
9.8.1 Oxford BioDynamics Details
9.8.2 Oxford BioDynamics Major Business
9.8.3 Oxford BioDynamics Pet Tumor Screening Services Product and Services
9.8.4 Oxford BioDynamics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Oxford BioDynamics Recent Developments/Updates
9.8.6 Oxford BioDynamics Competitive Strengths & Weaknesses
9.9 FUJIFILM VET Systems
9.9.1 FUJIFILM VET Systems Details
9.9.2 FUJIFILM VET Systems Major Business
9.9.3 FUJIFILM VET Systems Pet Tumor Screening Services Product and Services
9.9.4 FUJIFILM VET Systems Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 FUJIFILM VET Systems Recent Developments/Updates
9.9.6 FUJIFILM VET Systems Competitive Strengths & Weaknesses
9.10 Veterinary Pathology Group
9.10.1 Veterinary Pathology Group Details
9.10.2 Veterinary Pathology Group Major Business
9.10.3 Veterinary Pathology Group Pet Tumor Screening Services Product and Services
9.10.4 Veterinary Pathology Group Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Veterinary Pathology Group Recent Developments/Updates
9.10.6 Veterinary Pathology Group Competitive Strengths & Weaknesses
9.11 NationWide Laboratories
9.11.1 NationWide Laboratories Details
9.11.2 NationWide Laboratories Major Business
9.11.3 NationWide Laboratories Pet Tumor Screening Services Product and Services
9.11.4 NationWide Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 NationWide Laboratories Recent Developments/Updates
9.11.6 NationWide Laboratories Competitive Strengths & Weaknesses
9.12 BioGuard Corporation
9.12.1 BioGuard Corporation Details
9.12.2 BioGuard Corporation Major Business
9.12.3 BioGuard Corporation Pet Tumor Screening Services Product and Services
9.12.4 BioGuard Corporation Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BioGuard Corporation Recent Developments/Updates
9.12.6 BioGuard Corporation Competitive Strengths & Weaknesses
9.13 PETcision Biotech
9.13.1 PETcision Biotech Details
9.13.2 PETcision Biotech Major Business
9.13.3 PETcision Biotech Pet Tumor Screening Services Product and Services
9.13.4 PETcision Biotech Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 PETcision Biotech Recent Developments/Updates
9.13.6 PETcision Biotech Competitive Strengths & Weaknesses
9.14 Uni-Pharma
9.14.1 Uni-Pharma Details
9.14.2 Uni-Pharma Major Business
9.14.3 Uni-Pharma Pet Tumor Screening Services Product and Services
9.14.4 Uni-Pharma Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Uni-Pharma Recent Developments/Updates
9.14.6 Uni-Pharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pet Tumor Screening Services Industry Chain
10.2 Pet Tumor Screening Services Upstream Analysis
10.3 Pet Tumor Screening Services Midstream Analysis
10.4 Pet Tumor Screening Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Pet Tumor Screening Services Introduction
1.2 World Pet Tumor Screening Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Pet Tumor Screening Services Total Market by Region (by Headquarter Location)
1.3.1 World Pet Tumor Screening Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.3 China Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.4 Europe Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.5 Japan Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.6 South Korea Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.3.8 India Based Company Pet Tumor Screening Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pet Tumor Screening Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Pet Tumor Screening Services Consumption Value (2021-2032)
2.2 World Pet Tumor Screening Services Consumption Value by Region
2.2.1 World Pet Tumor Screening Services Consumption Value by Region (2021-2026)
2.2.2 World Pet Tumor Screening Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Pet Tumor Screening Services Consumption Value (2021-2032)
2.4 China Pet Tumor Screening Services Consumption Value (2021-2032)
2.5 Europe Pet Tumor Screening Services Consumption Value (2021-2032)
2.6 Japan Pet Tumor Screening Services Consumption Value (2021-2032)
2.7 South Korea Pet Tumor Screening Services Consumption Value (2021-2032)
2.8 ASEAN Pet Tumor Screening Services Consumption Value (2021-2032)
2.9 India Pet Tumor Screening Services Consumption Value (2021-2032)
3 WORLD PET TUMOR SCREENING SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Pet Tumor Screening Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Pet Tumor Screening Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Pet Tumor Screening Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Pet Tumor Screening Services in 2025
3.3 Pet Tumor Screening Services Company Evaluation Quadrant
3.4 Pet Tumor Screening Services Market: Overall Company Footprint Analysis
3.4.1 Pet Tumor Screening Services Market: Region Footprint
3.4.2 Pet Tumor Screening Services Market: Company Product Type Footprint
3.4.3 Pet Tumor Screening Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Pet Tumor Screening Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Pet Tumor Screening Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Pet Tumor Screening Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Pet Tumor Screening Services Consumption Value Comparison
4.2.1 United States VS China: Pet Tumor Screening Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pet Tumor Screening Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Pet Tumor Screening Services Companies and Market Share, 2021-2026
4.3.1 United States Based Pet Tumor Screening Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Pet Tumor Screening Services Revenue, (2021-2026)
4.4 China Based Companies Pet Tumor Screening Services Revenue and Market Share, 2021-2026
4.4.1 China Based Pet Tumor Screening Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Pet Tumor Screening Services Revenue, (2021-2026)
4.5 Rest of World Based Pet Tumor Screening Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Pet Tumor Screening Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Pet Tumor Screening Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pet Tumor Screening Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood Biomarker-Based Tumor Screening Services
5.2.2 Liquid Biopsy and Genomic Testing Services
5.2.3 Urine-Based or Volatile Metabolite Screening Services
5.2.4 AI Cytology and Digital Pathology Screening Services
5.3 Market Segment by Type
5.3.1 World Pet Tumor Screening Services Market Size by Type (2021-2026)
5.3.2 World Pet Tumor Screening Services Market Size by Type (2027-2032)
5.3.3 World Pet Tumor Screening Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY SERVICE DELIVERY MODEL
6.1 World Pet Tumor Screening Services Market Size Overview by Service Delivery Model: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Service Delivery Model
6.2.1 In-Clinic Point-of-Care Testing
6.2.2 Central Reference Laboratory Testing
6.2.3 At-Home Sample Collection and Mail-In Testing
6.2.4 Integrated Veterinary Oncology Screening Services
6.3 Market Segment by Service Delivery Model
6.3.1 World Pet Tumor Screening Services Market Size by Service Delivery Model (2021-2026)
6.3.2 World Pet Tumor Screening Services Market Size by Service Delivery Model (2027-2032)
6.3.3 World Pet Tumor Screening Services Market Size Market Share by Service Delivery Model (2027-2032)
7 MARKET ANALYSIS BY SCREENING PURPOSE
7.1 World Pet Tumor Screening Services Market Size Overview by Screening Purpose: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Screening Purpose
7.2.1 Annual Wellness Cancer Screening
7.2.2 Adjunctive Diagnosis for Suspected Cancer
7.2.3 Recurrence and Disease Monitoring
7.2.4 High-Risk Breed Screening
7.3 Market Segment by Screening Purpose
7.3.1 World Pet Tumor Screening Services Market Size by Screening Purpose (2021-2026)
7.3.2 World Pet Tumor Screening Services Market Size by Screening Purpose (2027-2032)
7.3.3 World Pet Tumor Screening Services Market Size Market Share by Screening Purpose (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Pet Tumor Screening Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pet Annual Wellness Checkups
8.2.2 Initial Tumor Screening in Veterinary Clinics
8.2.3 Post-Surgery and Post-Treatment Monitoring
8.2.4 Premium Pet Healthcare and Insurance-Linked Screening
8.3 Market Segment by Application
8.3.1 World Pet Tumor Screening Services Market Size by Application (2021-2026)
8.3.2 World Pet Tumor Screening Services Market Size by Application (2027-2032)
8.3.3 World Pet Tumor Screening Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 IDEXX Laboratories
9.1.1 IDEXX Laboratories Details
9.1.2 IDEXX Laboratories Major Business
9.1.3 IDEXX Laboratories Pet Tumor Screening Services Product and Services
9.1.4 IDEXX Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 IDEXX Laboratories Recent Developments/Updates
9.1.6 IDEXX Laboratories Competitive Strengths & Weaknesses
9.2 Zoetis Diagnostics
9.2.1 Zoetis Diagnostics Details
9.2.2 Zoetis Diagnostics Major Business
9.2.3 Zoetis Diagnostics Pet Tumor Screening Services Product and Services
9.2.4 Zoetis Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Zoetis Diagnostics Recent Developments/Updates
9.2.6 Zoetis Diagnostics Competitive Strengths & Weaknesses
9.3 Antech Diagnostics
9.3.1 Antech Diagnostics Details
9.3.2 Antech Diagnostics Major Business
9.3.3 Antech Diagnostics Pet Tumor Screening Services Product and Services
9.3.4 Antech Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Antech Diagnostics Recent Developments/Updates
9.3.6 Antech Diagnostics Competitive Strengths & Weaknesses
9.4 VolitionRx
9.4.1 VolitionRx Details
9.4.2 VolitionRx Major Business
9.4.3 VolitionRx Pet Tumor Screening Services Product and Services
9.4.4 VolitionRx Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 VolitionRx Recent Developments/Updates
9.4.6 VolitionRx Competitive Strengths & Weaknesses
9.5 VDI Laboratory
9.5.1 VDI Laboratory Details
9.5.2 VDI Laboratory Major Business
9.5.3 VDI Laboratory Pet Tumor Screening Services Product and Services
9.5.4 VDI Laboratory Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 VDI Laboratory Recent Developments/Updates
9.5.6 VDI Laboratory Competitive Strengths & Weaknesses
9.6 Oncotect
9.6.1 Oncotect Details
9.6.2 Oncotect Major Business
9.6.3 Oncotect Pet Tumor Screening Services Product and Services
9.6.4 Oncotect Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Oncotect Recent Developments/Updates
9.6.6 Oncotect Competitive Strengths & Weaknesses
9.7 CanCan Diagnostics
9.7.1 CanCan Diagnostics Details
9.7.2 CanCan Diagnostics Major Business
9.7.3 CanCan Diagnostics Pet Tumor Screening Services Product and Services
9.7.4 CanCan Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 CanCan Diagnostics Recent Developments/Updates
9.7.6 CanCan Diagnostics Competitive Strengths & Weaknesses
9.8 Oxford BioDynamics
9.8.1 Oxford BioDynamics Details
9.8.2 Oxford BioDynamics Major Business
9.8.3 Oxford BioDynamics Pet Tumor Screening Services Product and Services
9.8.4 Oxford BioDynamics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Oxford BioDynamics Recent Developments/Updates
9.8.6 Oxford BioDynamics Competitive Strengths & Weaknesses
9.9 FUJIFILM VET Systems
9.9.1 FUJIFILM VET Systems Details
9.9.2 FUJIFILM VET Systems Major Business
9.9.3 FUJIFILM VET Systems Pet Tumor Screening Services Product and Services
9.9.4 FUJIFILM VET Systems Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 FUJIFILM VET Systems Recent Developments/Updates
9.9.6 FUJIFILM VET Systems Competitive Strengths & Weaknesses
9.10 Veterinary Pathology Group
9.10.1 Veterinary Pathology Group Details
9.10.2 Veterinary Pathology Group Major Business
9.10.3 Veterinary Pathology Group Pet Tumor Screening Services Product and Services
9.10.4 Veterinary Pathology Group Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Veterinary Pathology Group Recent Developments/Updates
9.10.6 Veterinary Pathology Group Competitive Strengths & Weaknesses
9.11 NationWide Laboratories
9.11.1 NationWide Laboratories Details
9.11.2 NationWide Laboratories Major Business
9.11.3 NationWide Laboratories Pet Tumor Screening Services Product and Services
9.11.4 NationWide Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 NationWide Laboratories Recent Developments/Updates
9.11.6 NationWide Laboratories Competitive Strengths & Weaknesses
9.12 BioGuard Corporation
9.12.1 BioGuard Corporation Details
9.12.2 BioGuard Corporation Major Business
9.12.3 BioGuard Corporation Pet Tumor Screening Services Product and Services
9.12.4 BioGuard Corporation Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 BioGuard Corporation Recent Developments/Updates
9.12.6 BioGuard Corporation Competitive Strengths & Weaknesses
9.13 PETcision Biotech
9.13.1 PETcision Biotech Details
9.13.2 PETcision Biotech Major Business
9.13.3 PETcision Biotech Pet Tumor Screening Services Product and Services
9.13.4 PETcision Biotech Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 PETcision Biotech Recent Developments/Updates
9.13.6 PETcision Biotech Competitive Strengths & Weaknesses
9.14 Uni-Pharma
9.14.1 Uni-Pharma Details
9.14.2 Uni-Pharma Major Business
9.14.3 Uni-Pharma Pet Tumor Screening Services Product and Services
9.14.4 Uni-Pharma Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Uni-Pharma Recent Developments/Updates
9.14.6 Uni-Pharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Pet Tumor Screening Services Industry Chain
10.2 Pet Tumor Screening Services Upstream Analysis
10.3 Pet Tumor Screening Services Midstream Analysis
10.4 Pet Tumor Screening Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Pet Tumor Screening Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Pet Tumor Screening Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Pet Tumor Screening Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Pet Tumor Screening Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Pet Tumor Screening Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pet Tumor Screening Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Pet Tumor Screening Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Pet Tumor Screening Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Pet Tumor Screening Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Pet Tumor Screening Services Players in 2025
Table 12. World Pet Tumor Screening Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Pet Tumor Screening Services Company Evaluation Quadrant
Table 14. Head Office of Key Pet Tumor Screening Services Players
Table 15. Pet Tumor Screening Services Market: Company Product Type Footprint
Table 16. Pet Tumor Screening Services Market: Company Product Application Footprint
Table 17. Pet Tumor Screening Services Mergers & Acquisitions Activity
Table 18. United States VS China Pet Tumor Screening Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Pet Tumor Screening Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Pet Tumor Screening Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pet Tumor Screening Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Pet Tumor Screening Services Revenue Market Share (2021-2026)
Table 23. China Based Pet Tumor Screening Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pet Tumor Screening Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Pet Tumor Screening Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Pet Tumor Screening Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Pet Tumor Screening Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Pet Tumor Screening Services Revenue Market Share (2021-2026)
Table 29. World Pet Tumor Screening Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Pet Tumor Screening Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Pet Tumor Screening Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Pet Tumor Screening Services Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Table 33. World Pet Tumor Screening Services Market Size Value by Service Delivery Model (2021-2026) & (USD Million)
Table 34. World Pet Tumor Screening Services Market Size by Service Delivery Model (2027-2032) & (USD Million)
Table 35. World Pet Tumor Screening Services Market Size by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Table 36. World Pet Tumor Screening Services Market Size Value by Screening Purpose (2021-2026) & (USD Million)
Table 37. World Pet Tumor Screening Services Market Size by Screening Purpose (2027-2032) & (USD Million)
Table 38. World Pet Tumor Screening Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Pet Tumor Screening Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Pet Tumor Screening Services Market Size by Application (2027-2032) & (USD Million)
Table 41. IDEXX Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. IDEXX Laboratories Major Business
Table 43. IDEXX Laboratories Pet Tumor Screening Services Product and Services
Table 44. IDEXX Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. IDEXX Laboratories Recent Developments/Updates
Table 46. IDEXX Laboratories Competitive Strengths & Weaknesses
Table 47. Zoetis Diagnostics Basic Information, Manufacturing Base and Competitors
Table 48. Zoetis Diagnostics Major Business
Table 49. Zoetis Diagnostics Pet Tumor Screening Services Product and Services
Table 50. Zoetis Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Zoetis Diagnostics Recent Developments/Updates
Table 52. Zoetis Diagnostics Competitive Strengths & Weaknesses
Table 53. Antech Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Antech Diagnostics Major Business
Table 55. Antech Diagnostics Pet Tumor Screening Services Product and Services
Table 56. Antech Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Antech Diagnostics Recent Developments/Updates
Table 58. Antech Diagnostics Competitive Strengths & Weaknesses
Table 59. VolitionRx Basic Information, Manufacturing Base and Competitors
Table 60. VolitionRx Major Business
Table 61. VolitionRx Pet Tumor Screening Services Product and Services
Table 62. VolitionRx Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. VolitionRx Recent Developments/Updates
Table 64. VolitionRx Competitive Strengths & Weaknesses
Table 65. VDI Laboratory Basic Information, Manufacturing Base and Competitors
Table 66. VDI Laboratory Major Business
Table 67. VDI Laboratory Pet Tumor Screening Services Product and Services
Table 68. VDI Laboratory Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. VDI Laboratory Recent Developments/Updates
Table 70. VDI Laboratory Competitive Strengths & Weaknesses
Table 71. Oncotect Basic Information, Manufacturing Base and Competitors
Table 72. Oncotect Major Business
Table 73. Oncotect Pet Tumor Screening Services Product and Services
Table 74. Oncotect Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Oncotect Recent Developments/Updates
Table 76. Oncotect Competitive Strengths & Weaknesses
Table 77. CanCan Diagnostics Basic Information, Manufacturing Base and Competitors
Table 78. CanCan Diagnostics Major Business
Table 79. CanCan Diagnostics Pet Tumor Screening Services Product and Services
Table 80. CanCan Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CanCan Diagnostics Recent Developments/Updates
Table 82. CanCan Diagnostics Competitive Strengths & Weaknesses
Table 83. Oxford BioDynamics Basic Information, Manufacturing Base and Competitors
Table 84. Oxford BioDynamics Major Business
Table 85. Oxford BioDynamics Pet Tumor Screening Services Product and Services
Table 86. Oxford BioDynamics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Oxford BioDynamics Recent Developments/Updates
Table 88. Oxford BioDynamics Competitive Strengths & Weaknesses
Table 89. FUJIFILM VET Systems Basic Information, Manufacturing Base and Competitors
Table 90. FUJIFILM VET Systems Major Business
Table 91. FUJIFILM VET Systems Pet Tumor Screening Services Product and Services
Table 92. FUJIFILM VET Systems Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. FUJIFILM VET Systems Recent Developments/Updates
Table 94. FUJIFILM VET Systems Competitive Strengths & Weaknesses
Table 95. Veterinary Pathology Group Basic Information, Manufacturing Base and Competitors
Table 96. Veterinary Pathology Group Major Business
Table 97. Veterinary Pathology Group Pet Tumor Screening Services Product and Services
Table 98. Veterinary Pathology Group Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Veterinary Pathology Group Recent Developments/Updates
Table 100. Veterinary Pathology Group Competitive Strengths & Weaknesses
Table 101. NationWide Laboratories Basic Information, Manufacturing Base and Competitors
Table 102. NationWide Laboratories Major Business
Table 103. NationWide Laboratories Pet Tumor Screening Services Product and Services
Table 104. NationWide Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. NationWide Laboratories Recent Developments/Updates
Table 106. NationWide Laboratories Competitive Strengths & Weaknesses
Table 107. BioGuard Corporation Basic Information, Manufacturing Base and Competitors
Table 108. BioGuard Corporation Major Business
Table 109. BioGuard Corporation Pet Tumor Screening Services Product and Services
Table 110. BioGuard Corporation Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BioGuard Corporation Recent Developments/Updates
Table 112. BioGuard Corporation Competitive Strengths & Weaknesses
Table 113. PETcision Biotech Basic Information, Manufacturing Base and Competitors
Table 114. PETcision Biotech Major Business
Table 115. PETcision Biotech Pet Tumor Screening Services Product and Services
Table 116. PETcision Biotech Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. PETcision Biotech Recent Developments/Updates
Table 118. PETcision Biotech Competitive Strengths & Weaknesses
Table 119. Uni-Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Uni-Pharma Major Business
Table 121. Uni-Pharma Pet Tumor Screening Services Product and Services
Table 122. Uni-Pharma Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Uni-Pharma Recent Developments/Updates
Table 124. Uni-Pharma Competitive Strengths & Weaknesses
Table 125. Global Key Players of Pet Tumor Screening Services Upstream (Raw Materials)
Table 126. Global Pet Tumor Screening Services Typical Customers
Table 1. World Pet Tumor Screening Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Pet Tumor Screening Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Pet Tumor Screening Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Pet Tumor Screening Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Pet Tumor Screening Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Pet Tumor Screening Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Pet Tumor Screening Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Pet Tumor Screening Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Pet Tumor Screening Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Pet Tumor Screening Services Players in 2025
Table 12. World Pet Tumor Screening Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Pet Tumor Screening Services Company Evaluation Quadrant
Table 14. Head Office of Key Pet Tumor Screening Services Players
Table 15. Pet Tumor Screening Services Market: Company Product Type Footprint
Table 16. Pet Tumor Screening Services Market: Company Product Application Footprint
Table 17. Pet Tumor Screening Services Mergers & Acquisitions Activity
Table 18. United States VS China Pet Tumor Screening Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Pet Tumor Screening Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Pet Tumor Screening Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Pet Tumor Screening Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Pet Tumor Screening Services Revenue Market Share (2021-2026)
Table 23. China Based Pet Tumor Screening Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Pet Tumor Screening Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Pet Tumor Screening Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Pet Tumor Screening Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Pet Tumor Screening Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Pet Tumor Screening Services Revenue Market Share (2021-2026)
Table 29. World Pet Tumor Screening Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Pet Tumor Screening Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Pet Tumor Screening Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Pet Tumor Screening Services Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Table 33. World Pet Tumor Screening Services Market Size Value by Service Delivery Model (2021-2026) & (USD Million)
Table 34. World Pet Tumor Screening Services Market Size by Service Delivery Model (2027-2032) & (USD Million)
Table 35. World Pet Tumor Screening Services Market Size by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Table 36. World Pet Tumor Screening Services Market Size Value by Screening Purpose (2021-2026) & (USD Million)
Table 37. World Pet Tumor Screening Services Market Size by Screening Purpose (2027-2032) & (USD Million)
Table 38. World Pet Tumor Screening Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Pet Tumor Screening Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Pet Tumor Screening Services Market Size by Application (2027-2032) & (USD Million)
Table 41. IDEXX Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. IDEXX Laboratories Major Business
Table 43. IDEXX Laboratories Pet Tumor Screening Services Product and Services
Table 44. IDEXX Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. IDEXX Laboratories Recent Developments/Updates
Table 46. IDEXX Laboratories Competitive Strengths & Weaknesses
Table 47. Zoetis Diagnostics Basic Information, Manufacturing Base and Competitors
Table 48. Zoetis Diagnostics Major Business
Table 49. Zoetis Diagnostics Pet Tumor Screening Services Product and Services
Table 50. Zoetis Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Zoetis Diagnostics Recent Developments/Updates
Table 52. Zoetis Diagnostics Competitive Strengths & Weaknesses
Table 53. Antech Diagnostics Basic Information, Manufacturing Base and Competitors
Table 54. Antech Diagnostics Major Business
Table 55. Antech Diagnostics Pet Tumor Screening Services Product and Services
Table 56. Antech Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Antech Diagnostics Recent Developments/Updates
Table 58. Antech Diagnostics Competitive Strengths & Weaknesses
Table 59. VolitionRx Basic Information, Manufacturing Base and Competitors
Table 60. VolitionRx Major Business
Table 61. VolitionRx Pet Tumor Screening Services Product and Services
Table 62. VolitionRx Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. VolitionRx Recent Developments/Updates
Table 64. VolitionRx Competitive Strengths & Weaknesses
Table 65. VDI Laboratory Basic Information, Manufacturing Base and Competitors
Table 66. VDI Laboratory Major Business
Table 67. VDI Laboratory Pet Tumor Screening Services Product and Services
Table 68. VDI Laboratory Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. VDI Laboratory Recent Developments/Updates
Table 70. VDI Laboratory Competitive Strengths & Weaknesses
Table 71. Oncotect Basic Information, Manufacturing Base and Competitors
Table 72. Oncotect Major Business
Table 73. Oncotect Pet Tumor Screening Services Product and Services
Table 74. Oncotect Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Oncotect Recent Developments/Updates
Table 76. Oncotect Competitive Strengths & Weaknesses
Table 77. CanCan Diagnostics Basic Information, Manufacturing Base and Competitors
Table 78. CanCan Diagnostics Major Business
Table 79. CanCan Diagnostics Pet Tumor Screening Services Product and Services
Table 80. CanCan Diagnostics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. CanCan Diagnostics Recent Developments/Updates
Table 82. CanCan Diagnostics Competitive Strengths & Weaknesses
Table 83. Oxford BioDynamics Basic Information, Manufacturing Base and Competitors
Table 84. Oxford BioDynamics Major Business
Table 85. Oxford BioDynamics Pet Tumor Screening Services Product and Services
Table 86. Oxford BioDynamics Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Oxford BioDynamics Recent Developments/Updates
Table 88. Oxford BioDynamics Competitive Strengths & Weaknesses
Table 89. FUJIFILM VET Systems Basic Information, Manufacturing Base and Competitors
Table 90. FUJIFILM VET Systems Major Business
Table 91. FUJIFILM VET Systems Pet Tumor Screening Services Product and Services
Table 92. FUJIFILM VET Systems Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. FUJIFILM VET Systems Recent Developments/Updates
Table 94. FUJIFILM VET Systems Competitive Strengths & Weaknesses
Table 95. Veterinary Pathology Group Basic Information, Manufacturing Base and Competitors
Table 96. Veterinary Pathology Group Major Business
Table 97. Veterinary Pathology Group Pet Tumor Screening Services Product and Services
Table 98. Veterinary Pathology Group Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Veterinary Pathology Group Recent Developments/Updates
Table 100. Veterinary Pathology Group Competitive Strengths & Weaknesses
Table 101. NationWide Laboratories Basic Information, Manufacturing Base and Competitors
Table 102. NationWide Laboratories Major Business
Table 103. NationWide Laboratories Pet Tumor Screening Services Product and Services
Table 104. NationWide Laboratories Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. NationWide Laboratories Recent Developments/Updates
Table 106. NationWide Laboratories Competitive Strengths & Weaknesses
Table 107. BioGuard Corporation Basic Information, Manufacturing Base and Competitors
Table 108. BioGuard Corporation Major Business
Table 109. BioGuard Corporation Pet Tumor Screening Services Product and Services
Table 110. BioGuard Corporation Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. BioGuard Corporation Recent Developments/Updates
Table 112. BioGuard Corporation Competitive Strengths & Weaknesses
Table 113. PETcision Biotech Basic Information, Manufacturing Base and Competitors
Table 114. PETcision Biotech Major Business
Table 115. PETcision Biotech Pet Tumor Screening Services Product and Services
Table 116. PETcision Biotech Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. PETcision Biotech Recent Developments/Updates
Table 118. PETcision Biotech Competitive Strengths & Weaknesses
Table 119. Uni-Pharma Basic Information, Manufacturing Base and Competitors
Table 120. Uni-Pharma Major Business
Table 121. Uni-Pharma Pet Tumor Screening Services Product and Services
Table 122. Uni-Pharma Pet Tumor Screening Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Uni-Pharma Recent Developments/Updates
Table 124. Uni-Pharma Competitive Strengths & Weaknesses
Table 125. Global Key Players of Pet Tumor Screening Services Upstream (Raw Materials)
Table 126. Global Pet Tumor Screening Services Typical Customers
LIST OF FIGURES
Figure 1. Pet Tumor Screening Services Picture
Figure 2. World Pet Tumor Screening Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pet Tumor Screening Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Pet Tumor Screening Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Pet Tumor Screening Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 13. Pet Tumor Screening Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Pet Tumor Screening Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Pet Tumor Screening Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pet Tumor Screening Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pet Tumor Screening Services Markets in 2025
Figure 27. United States VS China: Pet Tumor Screening Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pet Tumor Screening Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Pet Tumor Screening Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Pet Tumor Screening Services Market Size Market Share by Type in 2025
Figure 31. Blood Biomarker-Based Tumor Screening Services
Figure 32. Liquid Biopsy and Genomic Testing Services
Figure 33. Urine-Based or Volatile Metabolite Screening Services
Figure 34. AI Cytology and Digital Pathology Screening Services
Figure 35. World Pet Tumor Screening Services Market Size Market Share by Type (2021-2032)
Figure 36. World Pet Tumor Screening Services Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Figure 37. World Pet Tumor Screening Services Market Size Market Share by Service Delivery Model in 2025
Figure 38. In-Clinic Point-of-Care Testing
Figure 39. Central Reference Laboratory Testing
Figure 40. At-Home Sample Collection and Mail-In Testing
Figure 41. Integrated Veterinary Oncology Screening Services
Figure 42. World Pet Tumor Screening Services Market Size Market Share by Service Delivery Model (2021-2032)
Figure 43. World Pet Tumor Screening Services Market Size by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Figure 44. World Pet Tumor Screening Services Market Size Market Share by Screening Purpose in 2025
Figure 45. Annual Wellness Cancer Screening
Figure 46. Adjunctive Diagnosis for Suspected Cancer
Figure 47. Recurrence and Disease Monitoring
Figure 48. High-Risk Breed Screening
Figure 49. World Pet Tumor Screening Services Market Size Market Share by Screening Purpose (2021-2032)
Figure 50. World Pet Tumor Screening Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Pet Tumor Screening Services Market Size Market Share by Application in 2025
Figure 52. Pet Annual Wellness Checkups
Figure 53. Initial Tumor Screening in Veterinary Clinics
Figure 54. Post-Surgery and Post-Treatment Monitoring
Figure 55. Premium Pet Healthcare and Insurance-Linked Screening
Figure 56. World Pet Tumor Screening Services Market Size Market Share by Application (2021-2032)
Figure 57. Pet Tumor Screening Services Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Pet Tumor Screening Services Picture
Figure 2. World Pet Tumor Screening Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pet Tumor Screening Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Pet Tumor Screening Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Pet Tumor Screening Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Pet Tumor Screening Services Revenue (2021-2032) & (USD Million)
Figure 13. Pet Tumor Screening Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Pet Tumor Screening Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Pet Tumor Screening Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Pet Tumor Screening Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Pet Tumor Screening Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Pet Tumor Screening Services Markets in 2025
Figure 27. United States VS China: Pet Tumor Screening Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pet Tumor Screening Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Pet Tumor Screening Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Pet Tumor Screening Services Market Size Market Share by Type in 2025
Figure 31. Blood Biomarker-Based Tumor Screening Services
Figure 32. Liquid Biopsy and Genomic Testing Services
Figure 33. Urine-Based or Volatile Metabolite Screening Services
Figure 34. AI Cytology and Digital Pathology Screening Services
Figure 35. World Pet Tumor Screening Services Market Size Market Share by Type (2021-2032)
Figure 36. World Pet Tumor Screening Services Market Size by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Figure 37. World Pet Tumor Screening Services Market Size Market Share by Service Delivery Model in 2025
Figure 38. In-Clinic Point-of-Care Testing
Figure 39. Central Reference Laboratory Testing
Figure 40. At-Home Sample Collection and Mail-In Testing
Figure 41. Integrated Veterinary Oncology Screening Services
Figure 42. World Pet Tumor Screening Services Market Size Market Share by Service Delivery Model (2021-2032)
Figure 43. World Pet Tumor Screening Services Market Size by Screening Purpose, (USD Million), 2021 & 2025 & 2032
Figure 44. World Pet Tumor Screening Services Market Size Market Share by Screening Purpose in 2025
Figure 45. Annual Wellness Cancer Screening
Figure 46. Adjunctive Diagnosis for Suspected Cancer
Figure 47. Recurrence and Disease Monitoring
Figure 48. High-Risk Breed Screening
Figure 49. World Pet Tumor Screening Services Market Size Market Share by Screening Purpose (2021-2032)
Figure 50. World Pet Tumor Screening Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Pet Tumor Screening Services Market Size Market Share by Application in 2025
Figure 52. Pet Annual Wellness Checkups
Figure 53. Initial Tumor Screening in Veterinary Clinics
Figure 54. Post-Surgery and Post-Treatment Monitoring
Figure 55. Premium Pet Healthcare and Insurance-Linked Screening
Figure 56. World Pet Tumor Screening Services Market Size Market Share by Application (2021-2032)
Figure 57. Pet Tumor Screening Services Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
